Pfizer
Tracy Aviles is an accomplished professional with extensive experience in clinical study management within the pharmaceutical and clinical research organizations. Currently serving as the Director and Clinical Study Team Lead at Pfizer since December 2020, Tracy previously held the position of Director of Project Management at IQVIA for a short tenure from June 2020 to December 2020. Tracy's career at ICON plc spanned nearly a decade, progressing from Senior Project/Program Manager to Director of Project Management between January 2011 and June 2020. Earlier experience includes serving as a Global Study Manager in the pharmaceutical CRO sector and as a Senior Global Study Manager at GlaxoSmithKline. Tracy holds a Master of Science in Clinical Research Administration from New York Medical College and a Bachelor of Science from Towson University.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.